Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-08-01 · accession 0001735276-24-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-02 | 2024-08-01 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $270.00 | -15.1K | 73.4K | -17% | -$4.09M |
| D | 2024-08-02 | 2024-08-01 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $85.00 | +15.1K | 88.6K | +21% | +$1.29M |
| D | 2024-08-02 | 2024-08-01 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | -15.1K | 17.4K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 15,148 | $270.00 | 73,441 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-01 | M | A | 15,148 | $85.00 | 88,589 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-08-01 | M | D | 15,148 | $0.00 | 17,352 | D | $85.00 · — to 2029-02-27 | 15,148 Common Stock | (F3) The stock option was fully vested as of 02/28/2023. |